Figure 1.
Platelet levels (109/L mean ± SD) and platelet transfusions among patients treated with tagraxofusp 12 μg/kg per day over time. (A) Platelet levels and platelet transfusions in the relapsed-refractory population. (B) Platelet levels and platelet transfusions in the treatment-naïve population. SD, standard deviation.